STOCK TITAN

CollPlant Biotechnologies Ltd (CLGN) EPS by Year

CLGN

CollPlant Biotechnologies Ltd lost $0.94 per diluted share in fiscal year 2025. This represents an increase of 35.2% from the prior fiscal year. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters CollPlant Biotechnologies Ltd has filed alongside them.

FY2025 annual
EPS (Diluted) -$0.94
YoY +35.2%
Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CLGN EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2520-FFY2420-FFY2320-FFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-K
EPS (Diluted)-$0.94+35.2%-$1.45-133.9%-$0.62+59.5%-$1.53-7750.0%$0.02-$0.84+62.3%-$2.23N/AN/A

CLGN EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2520-FQ2'256-KQ4'2420-FQ2'246-KQ4'2310-KQ2'2310-QQ4'2210-KQ2'2210-QQ4'2110-KQ2'2110-QQ4'2010-KQ2'2010-Q
EPS (Diluted)N/A$0.28-24.3%N/A$0.37-24.5%N/A$0.49+225.6%N/A-$0.39-30.0%N/A-$0.30N/AN/A

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More CollPlant Biotechnologies Ltd financials

Frequently Asked Questions

What was CollPlant Biotechnologies Ltd's diluted earnings per share in fiscal year 2025?

CollPlant Biotechnologies Ltd lost $0.94 per diluted share in fiscal year 2025.

How fast is CollPlant Biotechnologies Ltd's diluted earnings per share growing?

CollPlant Biotechnologies Ltd (CLGN) diluted earnings per share rose by 35.2% year over year, from -$1.45 to -$0.94 in fiscal year 2025.

What does diluted earnings per share mean on a financial statement?

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what CollPlant Biotechnologies Ltd (CLGN) reported on that line in every period on record.